account_id none on file
legal_name Mira Pharmaceuticals, Inc.
ticker MIRA
cik 1904286
domain mirapharmaceuticals.com
linkedin_company_url https://www.linkedin.com/company/mira-pharmaceuticals-inc/?viewAsMember=true
entry_point_account_id none on file
name MIRA Pharmaceuticals Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 4 executives 1 family 0
why_nownone on file
callsnone on file
filings
April 2024, the Company moved to a virtual office model and does not have a physical office space as of June 30, 2026 and December 31,
filing / Aug 12, 2026 / receipt
Weichselbaum was appointed as our Chief Financial Officer and Treasurer on May 19, 2025. Under the Employment Agreement with Mr.
filing / Jul 28, 2026 / receipt
Yanez was also appointed Chief Financial Officer on June 18, 2024. Andriy Mushak On June 2, 2026, the Board appointed Andriy Mushak to serve as the Company’s fractional Chief Financial Officer, effective June 6, 2026.
filing / Jul 28, 2026 / receipt
cost savings for companies. We and some brokers household proxy materials, delivering a single proxy statement to multiple shareholders
filing / Jul 28, 2026 / receipt
executives
| Alan Weichselbaum | Chief Financial Officer | - | receipt |
familynone on file
upcoming
| 2026-11-12 | earnings call | scheduled | ir |
changes
| 2025-05-21 | Chief Financial Officer, appointed | sec_8k |
mcp_package_hint
slug mira-pharmaceuticals-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$